IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 119 filers reported holding IMMUNITYBIO INC in Q1 2021. The put-call ratio across all filers is 2.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $199,358 | -39.9% | 117,963 | -1.2% | 0.00% | – |
| Q2 2023 | $331,837 | +228.4% | 119,366 | +115.0% | 0.00% | – |
| Q1 2023 | $101,060 | -55.6% | 55,527 | +23.8% | 0.00% | – |
| Q4 2022 | $227,380 | -0.7% | 44,848 | -2.4% | 0.00% | – |
| Q3 2022 | $229,000 | +45.9% | 45,973 | +9.4% | 0.00% | – |
| Q2 2022 | $157,000 | -12.8% | 42,037 | +30.8% | 0.00% | – |
| Q1 2022 | $180,000 | -4.3% | 32,139 | +3.8% | 0.00% | – |
| Q4 2021 | $188,000 | -37.5% | 30,976 | 0.0% | 0.00% | – |
| Q3 2021 | $301,000 | +69.1% | 30,976 | +149.4% | 0.00% | – |
| Q2 2021 | $178,000 | -20.5% | 12,421 | +31.8% | 0.00% | – |
| Q1 2021 | $224,000 | – | 9,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALLEN HOLDING INC /NY | 687,571 | $3,857,000 | 0.50% |
| ORACLE INVESTMENT MANAGEMENT INC | 400,013 | $2,244,000 | 0.44% |
| HARBOURVEST PARTNERS LLC | 335,709 | $1,883,000 | 0.38% |
| Winning Points Advisors, LLC | 60,126 | $339,000 | 0.26% |
| MERIDIAN INVESTMENT COUNSEL INC. | 96,433 | $541,000 | 0.19% |
| SHEETS SMITH WEALTH MANAGEMENT | 203,876 | $1,144,000 | 0.16% |
| Delphia (USA) Inc. | 25,504 | $143,000 | 0.11% |
| Clearwater Capital Advisors, LLC | 147,891 | $830,000 | 0.10% |
| Corton Capital Inc. | 36,843 | $207,000 | 0.09% |
| Virtus ETF Advisers LLC | 27,343 | $153,000 | 0.07% |